FIELD: medicine; oncology.
SUBSTANCE: invention can be used for nutritional support of patients during breast cancer chemotherapy. The method consists in conducting a course of treatment in two stages. At the first stage, chemotherapy is performed including intake of 60 mg/m2 of doxorubicin and 600 mg/m2 of cyclophosphamide for five days. At the second stage, nutritional support is carried out, for which the patient takes freeze-dried mare's milk dissolved in water at a temperature of 35–40°C at the rate of 20 g of freeze-dried mare's milk per 100–150 ml of water 3 times a day, 20–30 minutes before meals, for three weeks. Then the course, consisting of the previous two stages, is repeated three times.
EFFECT: improvement of general health indicators, emotional background, quality of life indicators and average haemoglobin level after chemotherapy.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH PRIMARILY OPERABLE AND LOCALLY ADVANCED INOPERABLE BREAST CANCER | 2017 |
|
RU2664597C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
METHOD FOR ASSESSMENT OF TUMOUR SENSITIVITY TO CHEMOTHERAPY OF PATIENTS WITH LOCALLY ADVANCED BREAST CANCER | 2015 |
|
RU2616532C1 |
METHOD OF THE TREATMENT OF PAIN IN POST-MASTECTOMY SYNDROME | 2022 |
|
RU2806297C1 |
METHOD FOR APPLYING ADJUVANT AND MEDICAMENTOUS MAMMARY GLAND CANCER THERAPY | 1999 |
|
RU2166938C1 |
METHOD FOR PERSONALIZED ASSIGNMENT OF NEOAJUVANT CHEMOTHERAPY TO PATIENTS SUFFERING FROM LUMINAL TYPE B BREAST CANCER | 2015 |
|
RU2594251C1 |
METHOD FOR TREATING LUMINAL SUBTYPE OF BREAST CANCER | 2018 |
|
RU2706029C1 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438659C1 |
PD-1/PD-L1 INHIBITORS FOR TREATING CANCER | 2016 |
|
RU2742312C1 |
Authors
Dates
2023-03-13—Published
2022-07-19—Filed